Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Sort descending Bone Marrow Disease
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management" American Journal of Hematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management American Journal of Hematology Myelodysplastic Syndromes (MDS)
Luspatercept use for lower risk myelodysplastic syndromes: Active but not enough American Journal of Hematology Myelodysplastic Syndromes (MDS)
Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision-Making American Journal of Hematology Aplastic Anemia
New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes American Society of Clinical Oncology Educational Book Myelodysplastic Syndromes (MDS)
Haploidentical stem cell transplantation (haplo-SCT) represents the main alternative for children with inherited bone marrow failure syndrome (I-BMF) lacking a matched donor. This retrospective study, conducted on behalf of the EBMT SAAWP and PDWP, aims t American Society of Clinical Oncology Educational Book Myelodysplastic Syndromes (MDS)
New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes American Society of Clinical Oncology Educational Book Myelodysplastic Syndromes (MDS)
Hemopoietic stem cell transplantation for infectious mononucleosis-related aplastic anemia Annals of Hematology Aplastic Anemia
Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.